伴焦虑痛苦特征抑郁症的临床诊治专家共识

2021-02-28 中国神经科学学会 精神医学杂志.2021.34(1):1-5.

焦虑性抑郁症是最常见的抑郁症亚型,在美国精神障碍诊断与统计手册第5 版( DSM-5) 诊断分类中提出抑郁症伴焦虑痛苦特征标注之后,凸显根据不同亚型与临床特征制定抑郁症个体化治疗方案的重要性。焦虑性抑

中文标题:

伴焦虑痛苦特征抑郁症的临床诊治专家共识

发布机构:

中国神经科学学会

发布日期:

2021-02-28

简要介绍:

焦虑性抑郁症是最常见的抑郁症亚型,在美国精神障碍诊断与统计手册第5 版( DSM-5) 诊断分类中提出抑郁症伴焦虑痛苦特征标注之后,凸显根据不同亚型与临床特征制定抑郁症个体化治疗方案的重要性。焦虑性抑郁症患者症状严重,病程迁延,认知功能损害严重,自杀风险高,临床治愈率低,给临床诊治带来很大挑战。本文结合国内外相关指南,在综合评价近年来国内外临床研究相关文献的基础上,形成针对伴焦虑痛苦特征抑郁症的专家意见,希望为临床实践提供借鉴和指导。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=伴焦虑痛苦特征抑郁症的临床诊治专家共识_刘晓华.pdf)] GetToolGuiderByIdResponse(projectId=1, id=fa3701c002106add, title=伴焦虑痛苦特征抑郁症的临床诊治专家共识, enTitle=, guiderFrom=精神医学杂志.2021.34(1):1-5., authorId=0, author=, summary=焦虑性抑郁症是最常见的抑郁症亚型,在美国精神障碍诊断与统计手册第5 版( DSM-5) 诊断分类中提出抑郁症伴焦虑痛苦特征标注之后,凸显根据不同亚型与临床特征制定抑郁症个体化治疗方案的重要性。焦虑性抑, cover=https://img.medsci.cn/2021525/1621951963091_2020535.jpg, journalId=0, articlesId=null, associationId=1301, associationName=中国神经科学学会, associationIntro=, copyright=0, guiderPublishedTime=Sun Feb 28 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>焦虑性抑郁症是最常见的抑郁症亚型,在美国精神障碍诊断与统计手册第5 版( DSM-5) 诊断分类中提出抑郁症伴焦虑痛苦特征标注之后,凸显根据不同亚型与临床特征制定抑郁症个体化治疗方案的重要性。焦虑性抑郁症患者症状严重,病程迁延,认知功能损害严重,自杀风险高,临床治愈率低,给临床诊治带来很大挑战。本文结合国内外相关指南,在综合评价近年来国内外临床研究相关文献的基础上,形成针对伴焦虑痛苦特征抑郁症的专家意见,希望为临床实践提供借鉴和指导。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=228, tagName=抑郁症)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=228, guiderKeyword=抑郁症, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9399, appHits=496, showAppHits=0, pcHits=872, showPcHits=8902, likes=8, shares=60, comments=24, approvalStatus=1, publishedTime=Tue May 25 22:37:22 CST 2021, publishedTimeString=2021-02-28, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue May 25 22:12:50 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 12:01:36 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=伴焦虑痛苦特征抑郁症的临床诊治专家共识_刘晓华.pdf)])
伴焦虑痛苦特征抑郁症的临床诊治专家共识_刘晓华.pdf
下载请点击:
评论区 (18)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2099831, encodeId=df63209983139, content=學習徐若曦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Fri Nov 11 10:40:40 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207377, encodeId=ff96120e377ee, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c212631393, createdName=283488816, createdTime=Wed Mar 30 23:02:19 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198788, encodeId=da991198e8854, content=值得参考, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048e6167235, createdName=ms1000001338777518, createdTime=Wed Mar 02 17:54:01 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189977, encodeId=45a511899e755, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae3e5710484, createdName=ms8000000908018201, createdTime=Thu Feb 03 17:47:01 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189784, encodeId=dc971189e84d4, content=值得认真读一读, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048e6167235, createdName=ms1000001338777518, createdTime=Wed Feb 02 22:00:54 CST 2022, time=2022-02-02, status=1, ipAttribution=)]
    2022-11-11 ozzy

    學習徐若曦

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2099831, encodeId=df63209983139, content=學習徐若曦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Fri Nov 11 10:40:40 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207377, encodeId=ff96120e377ee, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c212631393, createdName=283488816, createdTime=Wed Mar 30 23:02:19 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198788, encodeId=da991198e8854, content=值得参考, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048e6167235, createdName=ms1000001338777518, createdTime=Wed Mar 02 17:54:01 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189977, encodeId=45a511899e755, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae3e5710484, createdName=ms8000000908018201, createdTime=Thu Feb 03 17:47:01 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189784, encodeId=dc971189e84d4, content=值得认真读一读, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048e6167235, createdName=ms1000001338777518, createdTime=Wed Feb 02 22:00:54 CST 2022, time=2022-02-02, status=1, ipAttribution=)]
    2022-03-30 283488816

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2099831, encodeId=df63209983139, content=學習徐若曦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Fri Nov 11 10:40:40 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207377, encodeId=ff96120e377ee, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c212631393, createdName=283488816, createdTime=Wed Mar 30 23:02:19 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198788, encodeId=da991198e8854, content=值得参考, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048e6167235, createdName=ms1000001338777518, createdTime=Wed Mar 02 17:54:01 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189977, encodeId=45a511899e755, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae3e5710484, createdName=ms8000000908018201, createdTime=Thu Feb 03 17:47:01 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189784, encodeId=dc971189e84d4, content=值得认真读一读, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048e6167235, createdName=ms1000001338777518, createdTime=Wed Feb 02 22:00:54 CST 2022, time=2022-02-02, status=1, ipAttribution=)]
    2022-03-02 ms1000001338777518

    值得参考

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2099831, encodeId=df63209983139, content=學習徐若曦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Fri Nov 11 10:40:40 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207377, encodeId=ff96120e377ee, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c212631393, createdName=283488816, createdTime=Wed Mar 30 23:02:19 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198788, encodeId=da991198e8854, content=值得参考, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048e6167235, createdName=ms1000001338777518, createdTime=Wed Mar 02 17:54:01 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189977, encodeId=45a511899e755, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae3e5710484, createdName=ms8000000908018201, createdTime=Thu Feb 03 17:47:01 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189784, encodeId=dc971189e84d4, content=值得认真读一读, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048e6167235, createdName=ms1000001338777518, createdTime=Wed Feb 02 22:00:54 CST 2022, time=2022-02-02, status=1, ipAttribution=)]
    2022-02-03 ms8000000908018201

    学到了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2099831, encodeId=df63209983139, content=學習徐若曦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Fri Nov 11 10:40:40 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207377, encodeId=ff96120e377ee, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c212631393, createdName=283488816, createdTime=Wed Mar 30 23:02:19 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198788, encodeId=da991198e8854, content=值得参考, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048e6167235, createdName=ms1000001338777518, createdTime=Wed Mar 02 17:54:01 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189977, encodeId=45a511899e755, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae3e5710484, createdName=ms8000000908018201, createdTime=Thu Feb 03 17:47:01 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189784, encodeId=dc971189e84d4, content=值得认真读一读, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048e6167235, createdName=ms1000001338777518, createdTime=Wed Feb 02 22:00:54 CST 2022, time=2022-02-02, status=1, ipAttribution=)]
    2022-02-02 ms1000001338777518

    值得认真读一读

    0

拓展阅读

2016 CANMAT临床指南:成人抑郁症的管理

加拿大情绪和焦虑治疗网络(CANMAT,Canadian Network for Mood and Anxiety Treatments) · 2016-08-02

2016 ICSI卫生保健指南:抑郁症基层医疗管理(第17版)

临床系统改进协会(ICSI,Institute for Clinical Systems Improvement) · 2016-03-01

2016 EPA指南:慢性抑郁症的心理治疗

欧洲精神病学协会(EPA,European Psychiatric Association) · 2016-03-01

2016 USPSTF建议声明:儿童和青少年抑郁症筛查

美国预防医学工作组(USPSTF,U.S. Preventive Services Task Force) · 2016-02-09

2016 USPSTF建议声明:成人抑郁症筛查  

美国预防医学工作组(USPSTF,U.S. Preventive Services Task Force) · 2016-01-26